[PDF] Top 20 Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
Has 10000 "Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status." found on our website. Below are the top 20 most common "Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.".
Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
... known risk factors of breast cancer, in particular hormonal ...our dietary questionnaire did not cover soy ...levels by our study population (59), it is unlikely that their omission ... Voir le document complet
18
Prospective association between dietary pesticide exposure profiles and postmenopausal breast-cancer risk in the NutriNet-Santé cohort
... Daily Intake; EFSA: European Food and Safety Authority; ER-/PR-: Estrogen Receptor Negative/Progesterone Receptor Negative ; FFQ: Food Frequency Questionnaire; HCB: ... Voir le document complet
39
Progesterone receptor, obesity and prognosis in women diagnosed with estrogen receptor positive breast cancer
... PR status modifies the relation of obesity to the prognosis of women diagnosed with ER+ breast ...the breast cancer registry of the Centre des Maladies du Sein Deschênes-Fabia was used in ... Voir le document complet
79
No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study.
... with dietary data, without a history of cancer (except for skin basal cell carcinoma or breast lobular carcinoma in situ), and who were not consuming soy dietary supplements were ... Voir le document complet
6
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
... -positive breast cancer with the menopause-related ces- sation of ovarian estrogen and/or progesterone synthesis ...clinical and experimental evidence has clearly established a ... Voir le document complet
15
Plasma estrogen levels, estrogen receptor gene variation, and ischemic arterial disease in postmenopausal women: the three-city prospective cohort study.
... estradiol, estrogen receptor gene variation and ischemic arterial disease in postmenopausal women: the Three-City prospective Cohort Study " submitted for publication as an original ... Voir le document complet
30
Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort.
... hydrocarbon receptor (AhR, ...ER- breast cancer cell lines through AhR- dependent [39,40] or AhR-independent pathways ...complemented by animal stud- ies demonstrating that TCDD inhibits the ... Voir le document complet
11
Oral progestagens before menopause and breast cancer risk.
... dose) and hence could not analyse the risk associated with intermittent or continuous use or with ...benign breast disease’ and ‘personal history of benign uterine or ovarian disease’, ... Voir le document complet
8
Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.
... Subjects and methods E3N cohort The E3N cohort was set up in 1990 to investigate cancer risk factors ...France and insured with the Mutuelle Générale de l’Education Nationale (MGEN), a ... Voir le document complet
11
Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
... different risk association for a later age at first full-term childbirth with risk of HR-negative and HR-positive tumors, whereas the asso- ciations for parity related factors (such as ever having a ... Voir le document complet
13
Magi1, a new potential tumor suppressor gene in estrogen receptor positive breast cancer
... Breast cancer (BC) is a heterogeneous disease that differs at the genetic, histopathological and clinical levels [ 12 ...defined: Estrogen/Progesterone Receptor positive (ER + ... Voir le document complet
23
GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients
... case-control and prospective cohorts, have reinforced this association as well as identified over 90 additional breast cancer risk loci ...the estrogen receptor (ER) ... Voir le document complet
19
Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
... and cell ...cytoplasmic and nuclear compartments, the hormone-bound PRB was, as expected, fully translocated in the nucleus in 30 ...cytoplasm and the nucleus, and was especially condensed in ... Voir le document complet
36
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
... prepared and run under non-reducing conditions, then probed with anti-HER2 ...monomer and dimers, as determined by expected molecular weight, is ...conformation and possibly ... Voir le document complet
42
Lobular breast cancer: incidence and genetic and non-genetic risk factors.
... characterized by early onset of a variety of tumors. It is caused by mutations in the tumour-suppressor gene ...increased risk of sarcoma, premenopausal breast cancer, brain ... Voir le document complet
9
Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in Europe.
... summarized by line of ...cohorts by key treatment algorithms based on se- quence of hormone therapy and ...therapy and hormone therapy-refractory disease as relapsed during adjuvant therapy or ... Voir le document complet
12
Vitamin C Intake and Risk of Prostate Cancer: The Montreal PROtEuS Study
... cases and more modest (56%) in controls, raising the possibility of selection ...participants and non-participants, overall and by disease status, using census-based socio-economic ... Voir le document complet
9
25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies
... and risk of melanoma was observed across all subgroup ...cases and with moderate risk bias and in those adjusted for hair color, whereas association were not significant among studies ... Voir le document complet
16
Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women.
... folate intake on breast cancer risk may therefore be of greater significance in individuals with adequate intake of vitamin B 12 ...design and the high follow-up rates in the E3N ... Voir le document complet
7
Identification of genes involved in growth inhibition of breast cancer cells transduced with estrogen receptor.
... ABSTRACT Estrogen receptor alpha (ER α )-negative breast cancer cells display an aggressive ...ER-negative breast cancer cells leads to an estrogen-dependent down ... Voir le document complet
16
Sujets connexes